Inflammation in Sjögren's syndrome: Cause or consequence?

References

• Carsons, S. 2001. A review and update of Sjögren’s syndrome: manifestations, diagnosis and treatment. Am. J. Manag. Care. 7: 433–443
   PubMed Web of Science ®Google Scholar
• Zoukhri, D. 2006. Effect of inflammation on lacrimal gland function. Exp. Eye. Res. 82:885–898
   PubMed Web of Science ®Google Scholar
• Aqrawi, L. A., M. Kvarnström, K. A. Brokstad, et al 2014. Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome. Clin. Exp. Immunol. 177:244–252
   PubMed Web of Science ®Google Scholar
• Wei, P., C. Li, L. Qiang, et al 2015. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome. Med. Oral. Patol. Oral Cir. Bucal. 20:156–160
   Web of Science ®Google Scholar
• Mavragani, C. P., and H. M. Moutsopoulos. 2014. Sjögren syndrome. CMAJ. 186:579–586
   PubMed Web of Science ®Google Scholar
• Luciano, N., V. Valentini, A. Calabrò, et al 2015. One year in review 2015: Sjögren's syndrome. Clin. Exp. Rheumatol. 33:259–271
   PubMed Web of Science ®Google Scholar
• Tincani, A., L. Andreoli, I. Cavazzana, et al 2013. Novel aspects of Sjögren's syndrome in 2012. BMC Med. 11: 93–110
   PubMed Web of Science ®Google Scholar
• Shiboski, S. C., C. H. Shiboski, L. Criswell, et al 2012. American College of Rheumatology Classification Criteria for Sjögren’s syndrome: a data driven, expert consensus approach in the SICCA cohort. Arthiritis Care Res. 64: 475–487
   PubMed Web of Science ®Google Scholar
• Tzioufas, A. G., and M. Voulgarelis. 2007. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract. Res. Clin. Rheumatol. 21: 989–1010
   PubMed Web of Science ®Google Scholar
• Vitali, C., S. Bombardieri, R. Jonsson, et al 2002. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61: 554–558
   PubMed Web of Science ®Google Scholar
• Giovelli, R. A., M.C Santos, É.V. Serrano, V. Valim. 2015. Clinical characteristics and biopsy accuracy in suspected cases of Sjögren’s syndrome referred to labial salivary gland biopsy. BMC Musculoskelet. Disord. 16:30
   PubMed Web of Science ®Google Scholar
• Roescher, N., B. M. Lodde, J. L. Vosters, et al 2012. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome. Oral Dis. 18: 96–106
   PubMed Web of Science ®Google Scholar
• Delaleu, N., C. Q. Nguyen, A. B. Peck, and R. Jonsson. 2011. Sjögren's syndrome: studying the disease in mice. Arthritis Res. Ther. 13: 217
   PubMed Web of Science ®Google Scholar
• Nguyen, C. Q., and A. B. Peck. 2009. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul. Surf. 7: 11–27
   PubMed Web of Science ®Google Scholar
• Xiao, B., Y. Wang, P. S. Reinach, et al 2015. Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye. PloS One. 10: e0115333
   PubMedGoogle Scholar
• Alevizos, I., S. Alexander, R.J Turner G. G. Illei. 2011. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum. 63: 535–544
   PubMed Web of Science ®Google Scholar
• Alunno, A., L. Ibba-Manneschi, O. Bistoni, et al 2015. Telocytes in minor salivary glands of primary Sjögren’s syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis. J. Cell Mol. Med. 19: 1689–1696
   PubMed Web of Science ®Google Scholar
• Delaleu, N., H. Immervoll, J. Cornelius, R. Jonsson. 2008. Biomarker profiles in serum and saliva of experimental Sjögren’s syndrome: associations with specific autoimmune manifestations. Arthritis Res. Ther. 10: R22
   PubMed Web of Science ®Google Scholar
• Bookman, A. A., H. Shen, R.J Cook, et al 2011. Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren's syndrome but not patients with sicca. Arthritis Rheum. 63: 2014–2020
   PubMed Web of Science ®Google Scholar
• Contreras-Ruiz, L., B. Regenfuss, F. A. Mir, et al 2013. Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome. PloS One. 8: e75937
   PubMed Web of Science ®Google Scholar
• Mitsias, D. I., E. K. Kapsogeorgou, and H. M. Moutsopoulos. 2006. Sjögren's syndrome: why autoimmune epithelitis? Oral Dis. 12: 523–532
   PubMed Web of Science ®Google Scholar
• Tobón, G. J., J. O. Pers, V. Devauchelle-Pensec, P. Youinou. 2012. Neurological disorders in primary Sjögren's syndrome. Autoimmune Dis. 2012: 645967
   PubMedGoogle Scholar
• Dawson, L. J., P.C Fox, P. M. Smith. 2006. Sjögrens syndrome - the non-apoptotic model of glandular hypofunction. Reumathology (Oxford). 45: 792–798
   PubMed Web of Science ®Google Scholar
• Caulfield, V. L., C. Balmer, L. J. Dawson, P. M. Smith. 2009. A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology (Oxford). 48: 727–733
   PubMed Web of Science ®Google Scholar
• Correia, P. N., G. H. Carpenter, K. L. Paterson, G. B. Proctor. 2010. Inducible nitric oxide synthase increases secretion from inflamed salivary glands. Rheumatology (Oxford). 49: 48–56
   PubMed Web of Science ®Google Scholar
• Nandula, S. R., P. Dey, K. L. Corbin, et al 2013. Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling. J. Oral Pathol. Med. 42: 66–72
   PubMed Web of Science ®Google Scholar
• Gilboa-Geffen, A., Y. Wolf, G. Hanin, et al 2011. Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. PloS One. 6: e28727
   Google Scholar
• Low, H. Z., and T. Witte. 2011. Aspects of innate immunity in Sjögren's syndrome. Arthritis Res. Ther. 13: 218
   PubMed Web of Science ®Google Scholar
• Voulgarelis, M., and A. G. Tzioufas. 2010. Current aspects of pathogenesis in Sjögren's Syndrome. Ther. Adv. Musculoskelet. Dis. 2: 325–334
   PubMedGoogle Scholar
• Kapsogeorgou, E. K., M. I. Christodoulou, D. B. Panagiotakos, et al 2013. Minor salivary gland inflammatory lesions in Sjögren syndrome: do they evolve? J. Rheumatol. 40: 1566–1571
   PubMed Web of Science ®Google Scholar
• Hayashi, T. 2011. Dysfunction of lacrimal and salivary glands in Sjögren’s syndrome: nonimmunologic injury in preinflammatory phase and mouse model. J. Biomed. Biotechnol. 2011: 407031
   PubMedGoogle Scholar
• Nikolov, N. P., and G. G. Illei. 2009. Pathogenesis of Sjögren's syndrome. Curr. Opin. Rheumatol. 21: 465–470
   PubMed Web of Science ®Google Scholar
• Morrone, S. R., T. Wang, L. M. Constantoulakis, et al 2014. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc. Natl. Acad. Sci. U.S.A. 111: E62–E71
   Google Scholar
• Igoe, A., and R. H. Scofield. 2013. Autoimmunity and infection in Sjögren's syndrome. Curr. Opin. Rheumatol. 25: 480–487
   PubMed Web of Science ®Google Scholar
• Deshmukh, U. S., S. R. Nandula, P. R. Thimmalapura, et al 2009. Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function. J. Oral Pathol. Med. 38: 42–47
   PubMed Web of Science ®Google Scholar
• Deshmukh, U. S., Y. Ohyama, H. Bagavant, et al 2008. Inflammatory stimuli accelerate Sjögren's syndrome-like disease in (NZB x NZW)F1 mice. Arthritis Rheum. 58: 1318–1323
   PubMed Web of Science ®Google Scholar
• Bian, F., F. L. Barbosa, R. M. Corrales, et al 2015. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren’s syndrome. Arthritis Res. Ther. 17: 53
   PubMed Web of Science ®Google Scholar
• Gatumu, M. K., K. Skarstein, A. Papandile, et al 2009. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res. Ther. 11: R24
   PubMed Web of Science ®Google Scholar
• Jonsson, M. V., N. Delaleu, K. A. Brokstad, et al 2006. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 54: 2300–2305
   PubMed Web of Science ®Google Scholar
• Reksten, T. R., M. V. Jonsson, E. A. Szyszko, et al 2009. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren’s syndrome. Rheumatology (Oxford). 48: 1102–1106
   PubMed Web of Science ®Google Scholar
• Roescher, N., P. P. Tak, and G.G Illei. 2009. Cytokines in Sjögren's syndrome. Oral Dis. 15: 519–526
   PubMed Web of Science ®Google Scholar
• Chen, Y. T., K. Nikulina, S. Lazarev, et al 2010. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren’s syndrome. Am. J. Pathol. 177: 1333–1343
   PubMed Web of Science ®Google Scholar
• Theoharides, T. C., A. I. Petra AI, A. Taracanova, et al 2015. Targeting IL-33 in autoimmunity and inflammation. J Pharmacol. Exp. Ther. 354: 24–31
   PubMed Web of Science ®Google Scholar
• Bikker, A., J.M van Woerkom, A.A Kruize, et al 2010. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation. Arthritis Rheum. 62: 969–977
   PubMed Web of Science ®Google Scholar
• Jin, J. O., and Q. Yu. 2013. T cell-associated cytokines in the pathogenesis of Sjögren’s Syndrome. J. Clin. Cell. Immunol. S1: 1–9
   Google Scholar
• Zhang, X., W. Chen W, C. S. De Paiva, et al 2011. Desiccating stress induces CD4+ T-cell-mediated Sjögren’s syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-γ. Am. J. Pathol. 179: 1807–1814
   PubMed Web of Science ®Google Scholar
• De Paiva, C. S., C.S Hwang, J. D. Pitcher 3rd, et al 2010. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren’s syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford). 49: 246–258
   PubMed Web of Science ®Google Scholar
• Katsifis, G. E., S. Rekka, N.M Moutsopoulos, et al 2009. Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am. J. Pathol. 175: 1167–1177
   PubMed Web of Science ®Google Scholar
• Nguyen, C. Q., H. Yin, B. H. Lee, et al 2010. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res. Ther. 12: R220
   PubMed Web of Science ®Google Scholar
• De Paiva, C. S., E. A. Volpe, N. B. Gandhi, et al 2011. Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PloS One. 6: e29017
   PubMed Web of Science ®Google Scholar
• Hall, B. E., C. Zheng, W. D. Swaim, et al 2010. Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function. Lab. Invest. 90: 543–555
   PubMed Web of Science ®Google Scholar
• Szabo, K., G. Papp, B. Dezso, M. Zeher. 2014. The histopathology of labial salivary glands in primary Sjögren’s syndrome: focusing on follicular helper T cells in the inflammatory infiltrates. Mediators Inflamm. 2014: 631787
   PubMed Web of Science ®Google Scholar
• Coursey, T. G., and C. S. de Paiva. 2014. Managing Sjögren's syndrome and non-Sjögren syndrome dry eye with anti-inflammatory therapy. Clin. Ophthalmol. 8: 1447–1458
   PubMedGoogle Scholar
• Nandula, S. R., Y. M. Scindia, P. Dey. et al 2011. Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease. Oral Dis. 17: 801–807
   PubMed Web of Science ®Google Scholar
• Gliozzi, M., T. Greenwell-Wild, W. Jin, et al 2013. A link between interferon and augmented plasmin generation in exocrine gland damage in Sjögren's syndrome. J. Autoimmun. 40: 122–133
   PubMed Web of Science ®Google Scholar
• Bombardieri, M., F. Barone, D. Lucchesi, et al 2012. Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J. Immunol. 189: 3767–3776
   PubMed Web of Science ®Google Scholar
• Greenwell-Wild, T., N. M. Moutsopoulos, M. Gliozzi, et al 2011. Chitinases in the salivary glands and circulation of patients with Sjögren’s syndrome: macrophage harbingers of disease severity. Arthritis Rheum. 63: 3103–3115
   PubMed Web of Science ®Google Scholar
• Baldini, C., C. Rossi, F. Ferro et al 2013. The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome. J. Intern. Med. 274: 480–489
   PubMed Web of Science ®Google Scholar
• Zoukhri, D. 2010. Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells. Ocul. Surf. 8: 60–69
   PubMed Web of Science ®Google Scholar
• Contreras-Ruiz, L., A. Ghosh-Mitra, M. A. Shatos, et al 2013. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm. 2013: 636812
   PubMed Web of Science ®Google Scholar
• Sung, H. H., I. Castro, S. González, et al 2015. MUC1/SEC and MUC1/Y overexpression is associated with inflammation in Sjögren's syndrome. Oral Dis. 21: 730–738
   PubMed Web of Science ®Google Scholar
• Sisto, M., S. Lisi, G. Ingravallo, et al 2014. Neovascularization is prominent in the chronic inflammatory lesions of Sjögren's syndrome. Int. J. Exp. Pathol. 95: 131–137
   PubMed Web of Science ®Google Scholar
• McCall, A. D., and O. J. Baker. 2015. Characterization of angiogenesis and lymphangiogenesis in human minor salivary glands with Sjögren's syndrome. J. Histochem. Cytochem. 63: 340–349
   PubMed Web of Science ®Google Scholar
• Patel, R., and A. Shahane. 2014. The epidemiology of Sjögren's syndrome. Clin. Epidemiol. 6: 247–255
   PubMed Web of Science ®Google Scholar
• Lopalco, G., L. Cantarini, A. Vitale, et al 2015. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm. 2015: 194864
   PubMed Web of Science ®Google Scholar
• Theander, E., R. Manthorpe, and L. T. Jacobsson. 2004. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum. 50: 1262–1269
   PubMed Web of Science ®Google Scholar
• Guzmán, L. M., D. Castillo, S. O. Aguilera. 2010. Polymerase chain reaction (PCR) detection of B cell clonality in Sjögren's syndrome patients: a diagnostic tool of clonal expansion. Clin. Exp. Immunol. 161: 57–64
   PubMed Web of Science ®Google Scholar
• Theander, E., G. Henriksson, O. Ljungberg, et al 2006. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann. Rheum. Dis. 65: 796–803
   PubMed Web of Science ®Google Scholar
• Dong, L., Y. Chen, Y. Masaki, et al 2013. Possible mechanisms of lymphoma development in Sjögren's syndrome. Curr. Immunol. Rev. 9: 13–22
   PubMedGoogle Scholar
• Foulks, G. N., S. L. Forstot, P. C. Donshik, et al 2015. Clinical guidelines for management of dry eye associated with Sjögren disease. Ocul. Surf. 13: 118–132
   PubMed Web of Science ®Google Scholar
• Valim, V., V. F. M. Trevisani, J. M. de Sousa, et al 2015. Current approach to dry eye disease. Clin. Rev. Allergy Immunol. 49: 288–297
   PubMed Web of Science ®Google Scholar